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Abstract 
Background: Myanmar has the highest malaria incidence and attributed mortality in South East Asia with limited 
healthcare infrastructure to manage this burden. Establishing malaria Community Health Worker (CHW) programmes 
is one possible strategy to improve access to malaria diagnosis and treatment, particularly in remote areas. Despite 
considerable donor support for implementing CHW programmes in Myanmar, the cost implications are not well 
understood.
Methods: An ingredients based micro-costing approach was used to develop a model of the annual implemen-
tation cost of malaria CHWs in Myanmar. A cost model was constructed based on activity centres comprising of 
training, patient malaria services, monitoring and supervision, programme management, overheads and incentives. 
The model takes a provider perspective. Financial data on CHWs programmes were obtained from the 2013 financial 
reports of the Three Millennium Development Goal fund implementing partners that have been working on malaria 
control and elimination in Myanmar. Sensitivity and scenario analyses were undertaken to outline parameter uncer-
tainty and explore changes to programme cost for key assumptions.
Results: The range of total annual costs for the support of one CHW was US$ 966–2486. The largest driver of CHW 
cost was monitoring and supervision (31–60 % of annual CHW cost). Other important determinants of cost included 
programme management (15–28 % of annual CHW cost) and patient services (6–12 % of annual CHW cost). Within 
patient services, malaria rapid diagnostic tests are the major contributor to cost (64 % of patient service costs).
Conclusion: The annual cost of a malaria CHW in Myanmar varies considerably depending on the context and the 
design of the programme, in particular remoteness and the approach to monitoring and evaluation. The estimates 
provide information to policy makers and CHW programme planners in Myanmar as well as supporting economic 
evaluations of their cost-effectiveness.
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Background
Myanmar has the highest malaria incidence and attrib-
uted mortality in southeast Asia [1]. Historically, 
southeast Asia has been the epicentre of malaria drug 
resistance and resistance to artemisinin, the founda-
tion of antimalarial treatment globally, has spread in 
East and much of upper Myanmar [2–4]. Malaria ser-
vices are delivered by a wide range of governmental and 
non-governmental organisations as well as the private 
sector. Approximately 70  % of the population in Myan-
mar reside in rural areas [5]. A key challenge to effective 
malaria control in these settings is the limited health-
care infrastructure. Where health facilities have been 
upgraded staffing them with well-trained healthcare 
providers remains a challenge. Government health ser-
vices reach larger towns and villages but many of the 
most remote smaller villages have no coverage of health 
services.
In low income countries training and support of Com-
munity Health Workers (CHWs) has been identified as 
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one possible strategy to address the shortage of basic 
health services in areas where accessibility to health cen-
tres is limited. Malaria CHWs are trained to diagnose 
febrile patients with malaria rapid diagnostic test (RDT) 
and provide them with anti-malarial medication after 
parasitological confirmation. This aims to treat patients 
within 24 h of onset of fever while reducing unnecessary 
use of anti-malarial medication.
CHW programmes were found to be effective [6, 7] 
and cost-effective [8] in different settings and differ-
ent health areas [9, 10]. A cluster randomized trial con-
ducted in 2012 demonstrated modest improvements to 
malaria healthcare in Myanmar following the introduc-
tion of malaria CHWs [6] and a study related to this one 
has examined cost effectiveness and resource allocation 
scenarios of insecticide treated bed nets and malaria 
CHWs in Myanmar [11]. With the support of interna-
tional donors, the NMCP and implementing partners 
are expanding the CHWs programme. The cost of imple-
menting CHW programmes in Myanmar, however, is not 
well established. Estimating the full cost of a CHWs pro-
gramme is an important component of policy planning. 
This study estimates annual cost of CHWs given differ-
ent programmatic options and identifies key cost-driv-
ers, with the aim of helping policy makers plan malaria 
CHWs programmes in Myanmar.
Methods
Community health workers for malaria in Myanmar
CHWs are supposed to be nominated by village health 
committee. As village health committees are often not 
established or functioning, candidates for CHWs are 
often suggested by the village leader and the organization 
that supports the CHW or an NGO makes the final selec-
tion. The selection is usually based on criteria including 
education level and position in the community. Candi-
dates are often individuals that already provide informal 
health care in their community. CHWs can be of any gen-
der and aged between 18 and 50 years. They should have 
sufficient education to read and write Myanmar (Bur-
mese) language and preferably speak local dialects.
Malaria CHWs are trained to obtain simple history of 
malaria symptoms and use an RDT to screen for para-
sitaemia. Patients with a positive RDT are treated with 
the appropriate anti-malarial. Severe and complicated 
malaria patients are referred to the nearest hospital, 
and CHWs are instructed to report immediately to the 
health centre when there are unusual high occurrences of 
malaria or febrile patients in the community. In addition 
to malaria diagnosis and treatment they typically also 
provide health education and assist health staff during 
impregnation sessions of bed nets or the distribution of 
long-lasting insecticidal nets (LLINs) in the village. Some 
organizations have extended the role of their CHWs 
beyond malaria control to other diseases and interven-
tions, implying additional costs and potentially higher 
health benefits. While such diversification can improve 
the efficiency of CHW programmes [11], in this analysis 
the focus is restricted to their role in improving malaria 
diagnosis and treatment, and their cost is attributed fully 
to this aim.
Costing
An ingredients based micro-costing approach was used 
to develop a model of the annual implementation cost 
of a malaria CHW in Myanmar whereby all ‘ingredi-
ents’ necessary to implement a CHW programme are (1) 
identified, (2) measured and (3) valued. The cost model 
was constructed based on the activity cost centres for 
CHWs comprising training, patient services, monitoring 
and supervision, programme management, overheads 
and incentives. The model takes a provider perspec-
tive to help inform funders and programme managers 
on resource allocation and project planning. Costs to 
patients are excluded but considered to be very low since 
the CHWs are based in their community and services are 
usually free of charge.
A key aspect of this analysis was to consider how 
the cost of CHW programmes differs in more or less 
remote contexts. To this end, four remoteness strata 
were defined; easy, medium, difficult and very difficult to 
access. These strata are defined by incremental increases 
in travel costs and a change in the mode of monitoring 
and supervision; details below. The model is based on a 
set of key parameters, detailed in Table 1. Model param-
eters can be adjusted to observe the effect of programme 
variation or parameter uncertainty on programme costs.
Financial data on CHWs programmes were obtained 
from the 2013 financial reports of the Three Millennium 
Development Goal fund (3MDG) implementing partners 
that have been working on malaria in Myanmar. While 
the model uses data from the 3MDG reports, the analysis 
does not reflect any specific organisation or an average of 
the 3MDG programmes. Prices in local currency (Myan-
mar Kyat) were converted to US dollars using the mean 
interbank exchange rate for 2013 (1 US$  =  810  kyats) 
[12].
CHWs receive an initial training, which is typically sup-
plemented by annual refresher trainings, the number of 
which depends on the duration of the project. CHWs are 
initially trained in malaria prevention and behavioural 
change communication, treatment of uncomplicated 
malaria according to national treatment guidelines, and 
patient registration. Some programmes include malaria 
as part of a wider package of services, this analysis relates 
to malaria-specific CHWs.
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All ingredients identified in trainings were incorpo-
rated into the model including: travel costs for trainers, 
facilitators and trainees; food and accommodation, rental 
fees for training venue; expenses for stationary and learn-
ing aids; and fees for the trainers and facilitators. Total 
training costs were estimated depending on number 
of days and number of volunteers participating in the 
training.
Patient services include cost of commodities provided 
to CHWs to deliver malaria intervention and control 
to the community. The ingredients for patient services 
include: CHW kits, RDT and treatments for uncom-
plicated malaria (ACT plus single dose primaquine for 
Plasmodium falciparum malaria and chloroquine plus 
primaquine once a week over 8  weeks for Plasmodium 
vivax malaria). Anti-malarial medication and RDT are 
purchased separately by 3MDG and provided to imple-
menting partners; the wholesale procurement price 
is used for these items. Data on the number of malaria 
tests performed in fever cases in the community and the 
number of positive cases were obtained from programme 
reports. The expected cost of patient services is calcu-
lated as a function of testing and positivity rates.
CHWs are usually monitored on a regular basis. In 
easy and medium accessibility areas a focal health centre 
model is used for CHW monitoring and support meet-
ings. Once per month CHWs in the catchment area of a 
health centre meet to receive supplies, feed back data and 
receive general supervision. The proportion of CHWs 
attending monthly meetings is assumed to be 80  %. 
Supervisors also visit the villages quarterly to evaluate 
the CHWs’ work and to solve any problems the CHWs 
encounter. The ingredients for this activity include: travel 
cost for volunteers and supervisors; food and accommo-
dation allowance; rental fee for meeting venues; and per 
diems for both volunteers and supervisors. In difficult 
and very difficult to access areas, field supervision trips 
to CHWs are performed by a mobile health team every 
6 weeks as it is too burdensome for CHWs to travel to the 
nearest health facility. The teams provide on-site train-
ing and home visits of patients to evaluate the quality of 
the services performed and monitoring of correct use of 
Table 1 Community health worker costing model parameters
* Field supervision (remote settings)
** Health centre supervision (accessible settings)
Parameters Model input Lower value Upper value
Economic
 Exchange rate 810 699 1000
 Discount rate 3 % 0 % 8 %
Training
 Number of trainers 2 1 3
 Number of facilitators 1 1 3
 Number of CHWs in initial training 25 10 40
 Number of days for initial training 5 3 7
 Number of CHWs active year 3 1 5
 Number of CHWs in refresher training 55 30 90
 Frequency of refresher training per year 1 0.5 2
Patient services
 Number of tests performed by CHW per year 135 20 250
 Percentage of test positivity 14 % 1 % 50 %
 Test price 0.69 0.48 0.90
 Village size 500 100 671
Monitoring and supervision
 Number of field supervision per CHW* 8 4 12
 Number of meetings in health centre per year** 12 8 12
 Percentage of attendant in monthly meetings** 80 % 50 % 100 %
CHWs incentive
 Monthly incentive 20 5 50
 Incentive for negative test 0.2 0.2 0.5
 Incentive for positive test 0.3 0.3 1
 Overhead 10 %
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resources. There are three members in a mobile supervi-
sion team and at least three villages are supervised in one 
trip, requiring a total of 4  days per supervision trip. In 
addition the daily cost of transportation is raised incre-
mentally with remoteness category. The ingredients for 
this field supervision include travel cost for round trips 
and food, accommodation and salaries for malaria field 
supervisors.
Annual management cost for each CHW was calcu-
lated based on a hypothetical mid-sized organisation 
supporting 55 CHWs in five townships. For this model, 
all programme management is assumed to be undertaken 
by Myanmar nationals (rather than more expensive inter-
national staff). A 10  % overhead cost was applied to all 
cost centres except incentives to reflect office and utility 
costs. Incentives were included either as monthly fixed 
costs or according to performance of CHWs as detailed 
in the scenario analysis.
Opportunity costs of CHW time were estimated to 
explore full economic cost of CHW programme. The time 
contributed by CHW for malaria program were estimated 
and quantified the monetary value by multiplying aver-
age monthly salary in Myanmar US$ 180 per month [13]. 
These cost included time spent for training, patient ser-
vice and time spent for being monitored by the supervi-
sor. Time spent for each fever case by the CHW (24 min) 
was taken from a study in Ghana reporting the CHW 
working time in management of malaria in children [14].
Sensitivity and scenario analysis
CHW programmes vary considerably between set-
tings depending on a range of geographic, demographic, 
behavioural and programmatic factors. Scenario analy-
ses were carried out to reflect the variation in field set-
tings. Estimating annual cost of CHWs depends on the 
geographical location of the villages, epidemiology of 
malaria transmission, infrastructure such as accessibility 
of road condition, and transportation and other activities 
performed by the project.
Three dimensions of parameter variation are used in 
the scenario analysis (1) setting remoteness; (2) CHWs 
testing rate; and (3) financial incentives. These factors 
were identified as important to CHW programme costs 
during initial model development and through dialogue 
with programme managers and financial officers. The 
default number of RDT performed by each CHW is an 
average 135 per year, with an upper mean estimate of 250 
tests and 20 tests as a lower estimate, reflecting a range of 
malaria testing in the CHWs reporting data (unpublished 
data, National Malaria Control Programme). The organi-
zations implementing CHWs programmes in Myanmar 
use different incentive structures. The incentive schemes 
included here are (1) no incentive; (2) US$ 0.3 per RDT 
performed and US$ 5 per month; (3) US$ 0.5 per test and 
0.5 per treated patient; (4) US$ 20 per month.
One-way sensitivity analysis was performed on all 
programme and economic parameters to assess their 
impact on the model. The upper and lower limits data are 
detailed in Table 1 and the results are presented in a tor-
nado diagram.
The cost of financial remuneration (incentives) for 
CHW is a topic of interest to decision makers. The sce-
nario analysis presents different incentive models and 
incentive amounts based on active CHW programmes 
in Myanmar. In addition univariate sensitivity analysis 
is presented on a range of values for monthly incentives 
and per test incentives. The changes in cost per CHW 
per year are explored as incentives varying from US$ 0 
to 80 per month and US$ 0 to 4 per test. The incentive 
per test is more uncertain to the programme planner 
as it depends on the number of tests performed. This is 
included in the analysis, using testing rates sampled from 
a uniform distribution of the range in Table 1.
Results
Rather than present a single general cost estimate this 
study presents a range of cost estimates in illustrative 
scenarios. The range of costs over the three dimensions 
of the scenario analysis (remoteness, testing rate and 
incentives) is US$ 966–2486 as detailed in Table 2. The 
range of annual costs across varying levels of remote-
ness, assuming no incentives and 135 tests per year 
is US$ 1061–2151. The range across varying levels of 
incentives, assuming medium accessibility and 135 tests 
per year is US$ 1266–1428. When varying the testing 
rate, assuming medium accessibility and no incentives 
the annual costs ranged from US$ 1103 to 1293. The 
value (opportunity cost) of CHW working time per year 
was US$ 130 assuming a subsistence wage rate. On this 
basis the annual economic cost is slightly higher than the 
financial cost.
The annual cost of CHWs varied most in different 
remoteness settings. Figure 1 presents the proportional 
contributions to cost from each cost centre within each 
remoteness scenario. The largest driver of CHW cost is 
monitoring and supervision (31–60  % of annual CHW 
cost). This is significantly larger in difficult and very dif-
ficult to access settings, where support is provided by 
mobile health teams. Other important determinants 
of cost include programme management (15–28  % of 
annual CHW cost) and patient services (6–12  % of 
annual CHW cost). Within patient services, malaria 
RDT are the major contributor to cost (64 % of patient 
service costs).
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Univariate sensitivity analysis of programme and eco-
nomic variables (Fig.  2) finds that the number of field 
supervision meetings (assuming mobile field supervision) 
is the largest cost driver, followed by the average num-
ber of CHWs attending refresher trainings. Activities 
which are repeated over time and do not or might not 
benefit from economies of scale are expensive, such as 
mobile teams that regularly visits villages to provide sup-
port to one CHW at a time, or refresher trainings if only 
attended by a small number of CHWs.
The contribution of incentives to cost is, intuitively, 
highly sensitive to the size of the incentive. Figure 3 pre-
sents the rise from US$ 1253 to 2253 per CHW per year 
as incentives increase from US$ 0 to 80 per month and 
Table 2 Annual cost of malaria CHW in Myanmar with variation in remoteness, incentives and testing rate
Location Incentive Annual CHW cost (US$)
Number of malaria RDT performed per CHW
Default (135) Upper (250) Lower (20)
Easily accessible area No incentive 1061 1156 966
US$ 0.3 per test and US$ 5 per month 1128 1281 976
US$ 0.5 per test and US$ 0.5 per case 1161 1291 1032
US$ 20 per month 1301 1396 1206
Medium accessible area No incentive 1198 1293 1103
US$ 0.3 per test and US$ 5 per month 1266 1418 1113
US$ 0.5 per test and US$ 0.5 per case 1299 1428 1169
US$ 20 per month 1428 1533 1343
Difficult to access area No incentive 1986 2081 1891
US$ 0.3 per test and US$ 5 per month 2954 2206 1901
US$ 0.5 per test and US$ 0.5 per case 2087 2216 1957
US$ 20 per month 2226 2321 2131
Very difficult to access area No incentive 2151 2246 2056
US$ 0.3 per test and US$ 5 per month 2219 2371 2066
US$ 0.5 per test and US$ 0.5 per case 2252 2381 2122
US$ 20 per month 2391 2486 2296
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$2,500
Easy Medium Difficult Very 
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Incenves
Overheads
Programe management
Monitoring and supervision
Paent Services
Refresher Training
Inial Training
Fig. 1 Breakdown of annual cost of malaria CHW in Myanmar by remoteness strata
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between US$ 1294 and 2207 per CHW per year as incen-
tives increase from US$ 0 to 4 per test. Larger incen-
tives might also increase testing rates implying higher 
expenditure for additional tests and treatments; this is 
not modelled here due to lack of relevant data.
Discussion
This analysis provides guidance for comprehensive CHW 
programme budgeting, not only in the unit cost esti-
mates, but through a better understanding of the key 
determinants of CHW programme costs.
This study estimates the annual cost of CHWs for 
malaria control and elimination in Myanmar to be 
between approximately US$ 1000 and 2500 per year 
depending on the remoteness, testing rate and financial 
incentives provided to the CHW. This is lower than the 
annual cost from a recent modelling study in an African 
context, with a mean estimated annual cost of US$ 3584 
per CHW [15]. The main cost drivers are monitoring 
and supervision, programme management and patient 
services. Key programme variables are the number of 
field supervision visits per year; the average number of 
CHWs attending refresher trainings; the number of years 
a CHW is active for and the number of tests performed 
per year.
The cost of CHWs much depends on the geographi-
cal situation of the village. As CHWs aim to fill the gap 
of healthcare access inequity, they will be most needed 
in isolated villages in mountainous regions. The cost of 
maintaining CHWs in these areas will be high; field mon-
itoring and supervision was identified as a key cost driver 
and in these peripheral areas is expensive, but perhaps 
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Fig. 2 Variation in annual malaria CHW cost in Myanmar due to changes in a range of model parameters
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also exactly where the service is most necessary. With 
minimal education and limited initial training, regular 
supervision is necessary to ensure the quality of CHWs 
services.
In this cost model, CHWs are volunteers and usually 
do not get a salary but depending on the specific pro-
gramme and implementing organisation, they received 
incentives, either monetary or non-monetary such as, 
bags, umbrellas and torch lights printed with ministry of 
health logo. This paper outlines the contribution to pro-
gramme cost of some of the incentive models currently 
being employed in Myanmar, but further work is needed 
to understand the impact of these incentives.
Limitations
This cost analysis is based on financial reports of 3MDG 
and a review with programme managers, but not empiri-
cal measurement of CHWs cost. As such it is not an 
accurate reflection of the total economic costs of CHW 
activities. Only CHW activities relating to the man-
agement of febrile patients are included—diagnosing 
and treating malaria where appropriate and referring 
patients with danger signs. It did not include the cost of 
other malaria interventions that CHW might be involved 
with such as LLINs, IRS, IPT. In fact CHWs can be (and 
often are) active in care for other non-malarial causes 
of illness, implying higher costs on the one hand, but 
both the opportunity to share the costs with other pro-
grammes and with higher and more efficient returns on 
this investment.
Conclusion
A better understanding of the costs of CHWs in differ-
ent settings will improve policy makers’ and programme 
managers’ planning for malaria control and elimination 
in Myanmar. The costing model and its outputs will also 
be informative for economic evaluation of CHW activi-
ties that should account for factors such as the higher 
costs of maintaining CHWs in remote areas and the costs 
of different incentive schemes, as well as the varying 
returns on these investments.
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